Leadership Change at Sonora Quest Laboratories: Jennifer Erickson Succeeds David Dexter

Leadership Transition at Sonora Quest Laboratories: A New Era Begins

Sonora Quest Laboratories, the leading clinical laboratory testing provider in Arizona, is set to undergo a significant leadership transition as Jennifer Erickson is appointed as Chief Executive Officer-Elect. She succeeds David Dexter, who has dedicated over 26 years to the company and is scheduled to retire on March 31, 2026. Under Dexter's stewardship since 1999, Sonora Quest has become a pivotal player in the health care sector, conducting over 100 million diagnostic tests annually. His tenure is marked by transformative initiatives that have positioned the company at the forefront of clinical testing and patient care, including the innovative My Lab ReQuest™ platform introduced in 2015 and the accelerated COVID-19 testing initiative through Operation Catapult in 2020.

Erickson, who has a robust background in health care and consumer services, brings over 20 years of experience to her new role. Having previously served as the Chief Financial Officer (CFO) of Sonora Quest from 1999 to 2004, she is well-acquainted with the organization’s culture and operational dynamics. Dexter, who has mentored Erickson throughout her career, expresses confidence in her leadership capabilities, emphasizing her alignment with the company’s values of collaboration and accountability. Erickson’s recent position as CFO and Chief Operating Officer (COO) at Clin-Path Associates/Pathology Specialists of Arizona further equips her with the skills necessary to advance patient-centered diagnostics and bolster partnerships within the healthcare ecosystem.

As Erickson prepares to lead Sonora Quest, she aims to build upon the company's legacy of innovation and growth. Her strategic vision will focus on enhancing diagnostic services and improving patient access to testing, which is increasingly crucial in today’s healthcare landscape. With the ongoing evolution of medical technologies and the demand for rapid testing solutions, Erickson’s leadership is expected to guide Sonora Quest through these challenges while maintaining the high standards of quality and reliability that have characterized the organization under Dexter's tenure.

In addition to the leadership change, Sonora Quest Laboratories continues to emphasize its commitment to community health and partnerships. Collaborations with organizations like the American Cancer Society and CommunityCares highlight the company’s dedication to addressing public health needs. As the laboratory sector evolves, Sonora Quest is poised to adapt and innovate, ensuring that it remains a vital resource for diagnostic testing in Arizona and beyond.